MedPath

Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System

Completed
Conditions
HCV
Interventions
Diagnostic Test: Xpert HCV
Registration Number
NCT06508996
Lead Sponsor
Cepheid
Brief Summary

A multi-site prospective, all comers study that was conducted at geographically diverse locations in the United States.

Detailed Description

Whole blood specimens were collected from consented individuals with signs and symptoms and/or individuals at-risk of HCV infection, irrespective of HCV antibody status at a single timepoint.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1012
Inclusion Criteria
  • Participant was ≥18 years old
  • Participant was not on treatment at time of enrollment based on review of medical records or self-reported
  • Participant had signs and symptoms and/or is considered at-risk of HCV infection
Exclusion Criteria
  • Clinician assessed that the participant was not suitable for inclusion

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Capillary whole bloodXpert HCVCapillary whole blood from individuals with signs and symptoms and/or at-risk of HCV infection
Primary Outcome Measures
NameTimeMethod
Percent Agreement compared to Patient infected status (PIS)1 day

Clinical performance comparing Xpert test to PIS (NAAT + Antibody status)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Kentucky

🇺🇸

Lexington, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath